- daily renovating
- salicylic acid
- acne treatment
Designed to provide dermatologists with an efficient solution to address the issue of oil and acne-prone skin, the EFFACLAR skincare range features LHA, a unique micro-exfoliating agent to reveal smoother, healthier looking skin.
Innovation Anti-Relapse - For the 1st time. EFFACLAR K combines LHA with Retinyl Linoleate, a powerful retinol derivative specifically adapted to the needs of oily skin. Demonstrated to help prevent reappearance of skin imperfections. Optimum tolerance.
EFFACLAR K addresses acne-prone skin with clogged pores, blackheads and rough, uneven texture.
Properties: EFFACLAR K has been rigorously formulated with:
- 1.5% Salicylic Acid acne medication to treat acne and allow skin to heal.
- 0.3% LHA to micro-exfoliate the skin and stimulate cell renewal to transform and smooth skin texture.
- 0.5% Retinyl Linoleate for improved cell turnover to help prevent the reappearance of skin imperfections.
Results: Blackheads and skin imperfections are treated; pores are purified. Skin is transformed: more even, clearer, smoother. Lightweight, non greasy formula applies easily and leaves skin hydrated and fresh. Excellent make-up base.
Tolerance tested on acne-prone skin under dermatological control
Made in France